Prophylactic Human Papillomavirus Vaccines - Global Drug Forecast and Market Analysis to 2022

Industry: 

662 Views
Buy This Report

Prophylactic Human Papillomavirus Vaccines - Global Drug Forecast and Market Analysis to 2022 report provide global prophylactic human papillomavirus (HPV) vaccine market value is forecast to experience moderate growth over the coming years, climbing from $1.7 billion in 2012 to $2.2 billion by 2022, at a Compound Annual Growth Rate (CAGR) of 2.6% .

  • 662 reads